Beware of scams

We are aware of scams coming from email and social media where people try to impersonate us. We will never ask you for money or your bank details.

Learn more about what to look out for and how to protect yourself

Success Stories

Learn about the innovative, high-growth companies British Patient Capital is supporting

As the largest domestic investor into UK venture and venture growth opportunities, we have more than 1,000 businesses in our underlying portfolio. Here are just some examples of the dynamic companies we are backing.

Core Programme

Alchemab Therapeutics

Alchemab Therapeutics is a healthcare company that is harnessing the power of naturally protective antibodies to develop novel products for patients with hard-to-treat diseases.

Read the success story about Alchemab Therapeutics
Filter success stories
Filter Close filters
Filter success stories
Finance type
Sector
Nation/Region
Programme
Partner
Core Programme

Xampla

Xampla has developed an entirely new generation of materials, made from plants, that replaces plastics.

Core Programme

Ori Biotech

Ori Biotech’s mission is to eliminate barriers to patient access of cell and gene therapies (CGTs) through the use of innovation and by rethinking how those therapies are manufactured.

Core Programme

Quantexa

Quantexa is a data and analytics specialist which has developed a software platform for organisations to help them make meaningful, evidence-based decision using data and machine learning.

Core Programme

Thought Machine

Thought Machine is providing the next generation of core banking platforms using software it has built natively for cloud infrastructure to help banks move away from a reliance on outdated IT infrastructure.

Core Programme

Alchemab Therapeutics

Alchemab Therapeutics is a healthcare company that is harnessing the power of naturally protective antibodies to develop novel products for patients with hard-to-treat diseases.